Formulary Search Results for: ABIRATERONE ACETATE
8.3.4.2 Gonadorelin analogues and gonadotrophin-releasing hormone antagonists - View Category
Restrictions:
Restricted to specialist use in accordance with regional protocol [NHS network access required] for the indications below:
Metastatic castration resistant prostate cancer (mCRPC):
- Use in adult men in whom chemotherapy is not yet clinically indicated after failure of androgen deprivation therapy.
- Use in adult men who have received only one prior chemotherapy regimen.
- With prednisone or prednisolone for the treatment of newly diagnosed high-risk metastatic hormone sensitive prostate cancer in adult men in combination with androgen deprivation therapy.
Non-metastatic prostate cancer:
- Use of abiraterone acetate plus prednisolone in combination with androgen deprivation therapy for the treatment of high-risk hormone-sensitive non-metastatic prostate cancer (off label indication as approved by NCMAG).
Metastatic prostate cancer:
- Abiraterone acetate plus prednisolone in combination with androgen deprivation therapy for the treatment for newly diagnosed low-risk metastatic hormone-sensitive prostate cancer patients who are not suitable for currently accessible on-label alternatives (off label indication as approved by NCMAG).
11.4.1 Eye-corticosteroids - View Category
9.5.2.2 Phosphate-binding agents - View Category
7.3.2.2 Parenteral progestogen-only contraceptives - View Category
3.4.3 Allergic emergencies - View Category
Restrictions:
It is restricted to specialist use only on the advice of the Immunology Service.
8.3.2 Progestogens - View Category
8.2.5 Immunomodulating drugs used in Multiple Sclerosis - View Category
Restrictions:
Restricted to specialist use only. Restricted to use under the provision of the ‘Risk Sharing Scheme’ between the Scottish Executive Health Department and the manufacturers (NHS HDL (2002)6).
6.4.1.2 Progestogens - View Category
Prescribing Notes:
The use of medroxyprogesterone tablets for postponing menstruation is off-label, and only for use in patients at higher risk of VTE or where norethisterone is unsuitable. Further guidance is available from the Specialist Pharmacy Service.
13.6.1 Topical preparations for acne - View Category
4.8.1 Control of the epilepsies - View Category
Restrictions:
Restricted to initiation by specialists in epilepsy.
Prescribing Notes:
Use as monotherapy in the treatment of partial-onset seizures, with or without generalisation, in adults with newly diagnosed epilepsy is not recommended for use in NHSScotland by the SMC and is non-Formulary.